The FDA has approved Gazyva (obinutuzumab) as an add-on treatment for adults with lupus nephritis, Genentech said.
What is Gazyva for lupus nephritis? Gazyva (obinutuzumab) is a medication approved in the U.S. for adults with active lupus nephritis who are receiving standard therapies. The treatment is given via ...
Relief from lupus pain can be seen as a placeholder, not unlike that moment before a great discovery, writes columnist ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback